APA

Ljungars A., Mårtensson L., Mattsson J., Kovacek M., Sundberg A., Tornberg U., Jansson B., Persson N., Emruli V. K., Ek S., Jerkeman M., Hansson M., Juliusson G., Ohlin M., Frendéus B., Teige I. & Mattsson M. (2018). A platform for phenotypic discovery of therapeutic antibodies and targets applied on Chronic Lymphocytic Leukemia. : NPJ precision oncology.

Chicago

Ljungars A, Mårtensson L, Mattsson J, Kovacek M, Sundberg A, Tornberg U-C, Jansson B, Persson N, Emruli V Kuci, Ek S, Jerkeman M, Hansson M, Juliusson G, Ohlin M, Frendéus B, Teige I and Mattsson M. 2018. A platform for phenotypic discovery of therapeutic antibodies and targets applied on Chronic Lymphocytic Leukemia. : NPJ precision oncology.

Harvard

Ljungars A., Mårtensson L., Mattsson J., Kovacek M., Sundberg A., Tornberg U., Jansson B., Persson N., Emruli V. K., Ek S., Jerkeman M., Hansson M., Juliusson G., Ohlin M., Frendéus B., Teige I. and Mattsson M. (2018). A platform for phenotypic discovery of therapeutic antibodies and targets applied on Chronic Lymphocytic Leukemia. : NPJ precision oncology.

MLA

Ljungars A, Mårtensson L, Mattsson J, Kovacek M, Sundberg A, Tornberg U-C, Jansson B, Persson N, Emruli V Kuci, Ek S, Jerkeman M, Hansson M, Juliusson G, Ohlin M, Frendéus B, Teige I and Mattsson M. A platform for phenotypic discovery of therapeutic antibodies and targets applied on Chronic Lymphocytic Leukemia. : NPJ precision oncology. 2018.